Agios Pharmaceuticals | Nettoeinkommen

Aktienkurs
30.23
Täglich Wechseln
0.25 0.83%
Monatlich
6.78%
Jährlich
-14.94%
Q1 Prognose
29.30




Nettoeinkommen Veränderung Datum
AbbVie USD 1.82B 1.63B 2025-12
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Astellas Pharma JPY 100.38B 21.17B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bayer EUR -963M 764M 2025-09
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Exelixis USD 193.58M 8.73M 2025-09
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Novartis USD 3.93B 96M 2025-09
Novartis USD 3.93B 113M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12


Agios Pharmaceuticals Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.